Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact Source: ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020 Year: 2021
Effect of the risk factors on the characteristics of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Treatment and outcome of CRF patients with tuberculosis Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Predictive factors of sequelae among Tunisian patients treated for pulmonary tuberculosis. Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003
Predictive factors of relapse in pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004
Prevalence and risk factors of frailty in patients with mycobacterium avium complex lung disease-preliminary study- Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study Source: Eur Respir J, 55 (1) 1900798; 10.1183/13993003.00798-2019 Year: 2020
Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis Source: Eur Respir J 2008; 32: 1031-1036 Year: 2008
Clinical profile and outcome of complicated pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002
The factors associated to pulmonary impairment in patients with treated tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Pulmonary tuberculosis relapse: predisposing factors and management in Tunisia Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006